

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | myelination (GO:0042552) | 5.94780763 |
| 2 | ensheathment of neurons (GO:0007272) | 5.93416529 |
| 3 | axon ensheathment (GO:0008366) | 5.93416529 |
| 4 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.90874914 |
| 5 | fatty acid elongation (GO:0030497) | 5.77843287 |
| 6 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.66237572 |
| 7 | actin-myosin filament sliding (GO:0033275) | 5.56488349 |
| 8 | muscle filament sliding (GO:0030049) | 5.56488349 |
| 9 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.54832633 |
| 10 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 5.51127898 |
| 11 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.47486537 |
| 12 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 5.23475680 |
| 13 | regulation of relaxation of muscle (GO:1901077) | 5.22683015 |
| 14 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 5.16200876 |
| 15 | long-chain fatty acid biosynthetic process (GO:0042759) | 5.07568472 |
| 16 | myofibril assembly (GO:0030239) | 5.04476524 |
| 17 | regulation of actin filament-based movement (GO:1903115) | 4.92358637 |
| 18 | cardiac muscle contraction (GO:0060048) | 4.89580667 |
| 19 | cardiac myofibril assembly (GO:0055003) | 4.84167203 |
| 20 | sarcomere organization (GO:0045214) | 4.77412234 |
| 21 | negative regulation of neurotransmitter transport (GO:0051589) | 4.76639048 |
| 22 | negative regulation of neurotransmitter secretion (GO:0046929) | 4.75338654 |
| 23 | cardiac muscle hypertrophy (GO:0003300) | 4.72345762 |
| 24 | L-amino acid import (GO:0043092) | 4.67862277 |
| 25 | actin-mediated cell contraction (GO:0070252) | 4.58511589 |
| 26 | regulation of cell communication by electrical coupling (GO:0010649) | 4.57562909 |
| 27 | striated muscle hypertrophy (GO:0014897) | 4.46666469 |
| 28 | striated muscle contraction (GO:0006941) | 4.46092282 |
| 29 | myelin maintenance (GO:0043217) | 4.44148160 |
| 30 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.39524956 |
| 31 | cell communication by electrical coupling (GO:0010644) | 4.22148934 |
| 32 | presynaptic membrane organization (GO:0097090) | 4.12828332 |
| 33 | response to inactivity (GO:0014854) | 4.06462428 |
| 34 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.03350933 |
| 35 | presynaptic membrane assembly (GO:0097105) | 3.98702527 |
| 36 | muscle hypertrophy (GO:0014896) | 3.97950890 |
| 37 | glycerophospholipid catabolic process (GO:0046475) | 3.97118925 |
| 38 | relaxation of cardiac muscle (GO:0055119) | 3.96743597 |
| 39 | neuron cell-cell adhesion (GO:0007158) | 3.94302313 |
| 40 | eye photoreceptor cell differentiation (GO:0001754) | 3.93618582 |
| 41 | photoreceptor cell differentiation (GO:0046530) | 3.93618582 |
| 42 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.92782551 |
| 43 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.91238310 |
| 44 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.83866515 |
| 45 | oligodendrocyte differentiation (GO:0048709) | 3.82925158 |
| 46 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.76395701 |
| 47 | cardiac muscle adaptation (GO:0014887) | 3.73486889 |
| 48 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.73486889 |
| 49 | muscle hypertrophy in response to stress (GO:0003299) | 3.73486889 |
| 50 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.72574482 |
| 51 | negative regulation of protein localization to cell surface (GO:2000009) | 3.72019471 |
| 52 | regulation of striated muscle contraction (GO:0006942) | 3.71406972 |
| 53 | cell communication involved in cardiac conduction (GO:0086065) | 3.70506552 |
| 54 | regulation of skeletal muscle contraction (GO:0014819) | 3.69005120 |
| 55 | regulation of collateral sprouting (GO:0048670) | 3.66482913 |
| 56 | import into cell (GO:0098657) | 3.62698234 |
| 57 | establishment of mitochondrion localization (GO:0051654) | 3.62089733 |
| 58 | detection of calcium ion (GO:0005513) | 3.56897570 |
| 59 | neuronal action potential propagation (GO:0019227) | 3.55677375 |
| 60 | amino acid import (GO:0043090) | 3.53515333 |
| 61 | actin filament-based movement (GO:0030048) | 3.52793618 |
| 62 | astrocyte development (GO:0014002) | 3.50578667 |
| 63 | asymmetric protein localization (GO:0008105) | 3.49938662 |
| 64 | adult walking behavior (GO:0007628) | 3.49405937 |
| 65 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.44411302 |
| 66 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.44411302 |
| 67 | regulation of membrane repolarization (GO:0060306) | 3.44146561 |
| 68 | actomyosin structure organization (GO:0031032) | 3.44073401 |
| 69 | skeletal muscle contraction (GO:0003009) | 3.41960969 |
| 70 | apical protein localization (GO:0045176) | 3.41708963 |
| 71 | transmission of nerve impulse (GO:0019226) | 3.40858150 |
| 72 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.39956929 |
| 73 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.39375500 |
| 74 | relaxation of muscle (GO:0090075) | 3.34827148 |
| 75 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.33917943 |
| 76 | response to epinephrine (GO:0071871) | 3.33854550 |
| 77 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.33235077 |
| 78 | neuron remodeling (GO:0016322) | 3.29599952 |
| 79 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 3.29447614 |
| 80 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.26911930 |
| 81 | regulation of cardiac muscle contraction (GO:0055117) | 3.26520607 |
| 82 | response to methylmercury (GO:0051597) | 3.24694374 |
| 83 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.22080628 |
| 84 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.16975770 |
| 85 | sodium ion export (GO:0071436) | 3.15556581 |
| 86 | regulation of the force of heart contraction (GO:0002026) | 3.14248824 |
| 87 | neurotransmitter uptake (GO:0001504) | 3.13923484 |
| 88 | substantia nigra development (GO:0021762) | 3.07699823 |
| 89 | activation of protein kinase A activity (GO:0034199) | 3.05678134 |
| 90 | muscle contraction (GO:0006936) | 3.05588801 |
| 91 | negative regulation of axonogenesis (GO:0050771) | 3.03918142 |
| 92 | striated muscle adaptation (GO:0014888) | 3.02553115 |
| 93 | cellular potassium ion homeostasis (GO:0030007) | 3.02511840 |
| 94 | potassium ion import (GO:0010107) | 3.02380358 |
| 95 | nerve growth factor signaling pathway (GO:0038180) | 3.01652837 |
| 96 | adult heart development (GO:0007512) | 3.00512443 |
| 97 | cardiac muscle cell development (GO:0055013) | 3.00318180 |
| 98 | neuronal ion channel clustering (GO:0045161) | 2.99425869 |
| 99 | peripheral nervous system axon ensheathment (GO:0032292) | 2.99246786 |
| 100 | myelination in peripheral nervous system (GO:0022011) | 2.99246786 |
| 101 | dendritic spine morphogenesis (GO:0060997) | 2.98365362 |
| 102 | membrane depolarization during action potential (GO:0086010) | 2.97682461 |
| 103 | cardiac cell development (GO:0055006) | 2.97359324 |
| 104 | neuron recognition (GO:0008038) | 2.96049558 |
| 105 | muscle tissue morphogenesis (GO:0060415) | 2.95528125 |
| 106 | membrane tubulation (GO:0097320) | 2.95304964 |
| 107 | creatine metabolic process (GO:0006600) | 2.94767970 |
| 108 | cholesterol biosynthetic process (GO:0006695) | 2.93843615 |
| 109 | muscle system process (GO:0003012) | 2.88956856 |
| 110 | regulation of heart rate (GO:0002027) | 2.88739994 |
| 111 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.85196926 |
| 112 | protein palmitoylation (GO:0018345) | 2.84244083 |
| 113 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.83620671 |
| 114 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 2.82143133 |
| 115 | mating behavior (GO:0007617) | 2.80239941 |
| 116 | positive regulation of action potential (GO:0045760) | 2.78440598 |
| 117 | response to redox state (GO:0051775) | 2.78245133 |
| 118 | synaptic vesicle maturation (GO:0016188) | 2.77369600 |
| 119 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.77157039 |
| 120 | positive regulation of cation channel activity (GO:2001259) | 2.75175425 |
| 121 | regulation of heart contraction (GO:0008016) | 2.73798696 |
| 122 | regulation of cation channel activity (GO:2001257) | 2.72790838 |
| 123 | amyloid precursor protein metabolic process (GO:0042982) | 2.72678135 |
| 124 | limb bud formation (GO:0060174) | 2.69667100 |
| 125 | negative regulation of inclusion body assembly (GO:0090084) | 2.69310469 |
| 126 | cerebellar granule cell differentiation (GO:0021707) | 2.68693183 |
| 127 | negative regulation of axon extension (GO:0030517) | 2.68515093 |
| 128 | cellular response to epinephrine stimulus (GO:0071872) | 2.67642344 |
| 129 | cardiac muscle cell action potential (GO:0086001) | 2.66956082 |
| 130 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.66534516 |
| 131 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.66531317 |
| 132 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.65767153 |
| 133 | response to lipoprotein particle (GO:0055094) | 2.65686186 |
| 134 | magnesium ion transport (GO:0015693) | 2.65014620 |
| 135 | cGMP-mediated signaling (GO:0019934) | 2.64151041 |
| 136 | axon development (GO:0061564) | 2.63133959 |
| 137 | regulation of dopamine metabolic process (GO:0042053) | 2.61507608 |
| 138 | regulation of catecholamine metabolic process (GO:0042069) | 2.61507608 |
| 139 | positive regulation of potassium ion transport (GO:0043268) | 2.60996695 |
| 140 | axonal fasciculation (GO:0007413) | 2.60042744 |
| 141 | sterol biosynthetic process (GO:0016126) | 2.59605794 |
| 142 | positive regulation of heart rate (GO:0010460) | 2.58339058 |
| 143 | cellular response to catecholamine stimulus (GO:0071870) | 2.58213841 |
| 144 | cellular response to monoamine stimulus (GO:0071868) | 2.58213841 |
| 145 | adhesion of symbiont to host cell (GO:0044650) | 2.57524073 |
| 146 | virion attachment to host cell (GO:0019062) | 2.57524073 |
| 147 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.57115755 |
| 148 | regulation of sarcomere organization (GO:0060297) | 2.57093020 |
| 149 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.56676709 |
| 150 | organ growth (GO:0035265) | 2.56524827 |
| 151 | dopamine biosynthetic process (GO:0042416) | 2.56464466 |
| 152 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.56356919 |
| 153 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.54879997 |
| 154 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.54814504 |
| 155 | regulation of muscle system process (GO:0090257) | 2.54045647 |
| 156 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.53832328 |
| 157 | peripheral nervous system development (GO:0007422) | 2.53339316 |
| 158 | cAMP catabolic process (GO:0006198) | 2.52532294 |
| 159 | auditory behavior (GO:0031223) | 2.51261569 |
| 160 | cardiac chamber formation (GO:0003207) | 2.51214258 |
| 161 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.51028892 |
| 162 | cardiac ventricle formation (GO:0003211) | 2.50252777 |
| 163 | membrane assembly (GO:0071709) | 2.49761808 |
| 164 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.49560899 |
| 165 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.49267698 |
| 166 | dendrite morphogenesis (GO:0048813) | 2.49040159 |
| 167 | isoprenoid biosynthetic process (GO:0008299) | 2.48811829 |
| 168 | adult locomotory behavior (GO:0008344) | 2.48513451 |
| 169 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.47876934 |
| 170 | glycine transport (GO:0015816) | 2.47377011 |
| 171 | gamma-aminobutyric acid transport (GO:0015812) | 2.46830459 |
| 172 | enteric nervous system development (GO:0048484) | 2.46722916 |
| 173 | mechanosensory behavior (GO:0007638) | 2.46609119 |
| 174 | negative regulation of synaptic transmission (GO:0050805) | 2.45927061 |
| 175 | neurotransmitter catabolic process (GO:0042135) | 2.44374937 |
| 176 | cyclic nucleotide catabolic process (GO:0009214) | 2.43869968 |
| 177 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.43510982 |
| 178 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.43510982 |
| 179 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.40673137 |
| 180 | Golgi to endosome transport (GO:0006895) | 2.40552141 |
| 181 | dendrite development (GO:0016358) | 2.37776686 |
| 182 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.36639693 |
| 183 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.36639693 |
| 184 | neuron-neuron synaptic transmission (GO:0007270) | 2.35759904 |
| 185 | glycosylceramide metabolic process (GO:0006677) | 2.35735909 |
| 186 | central nervous system myelination (GO:0022010) | 10.2653042 |
| 187 | axon ensheathment in central nervous system (GO:0032291) | 10.2653042 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.66253523 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.64086721 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.64019804 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.63318357 |
| 5 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.56658876 |
| 6 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.27367812 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.27367812 |
| 8 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.27147995 |
| 9 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.25259513 |
| 10 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.21700804 |
| 11 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.20365010 |
| 12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.19822162 |
| 13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.19532640 |
| 14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.18522663 |
| 15 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.18268011 |
| 16 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.11435087 |
| 17 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.10984332 |
| 18 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.06709722 |
| 19 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.99625808 |
| 20 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.97632199 |
| 21 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.95442384 |
| 22 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.95350802 |
| 23 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.95005899 |
| 24 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.93694852 |
| 25 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.83585214 |
| 26 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.82322473 |
| 27 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.79748081 |
| 28 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.77618547 |
| 29 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.72326056 |
| 30 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.68044458 |
| 31 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.59685402 |
| 32 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.57897735 |
| 33 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.57290575 |
| 34 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.56911934 |
| 35 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.56312225 |
| 36 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.56184208 |
| 37 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.55362485 |
| 38 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.52963766 |
| 39 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.52791572 |
| 40 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.51948221 |
| 41 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.49020918 |
| 42 | P300_19829295_ChIP-Seq_ESCs_Human | 1.48643701 |
| 43 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.48598432 |
| 44 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.47310795 |
| 45 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.46774180 |
| 46 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.43635184 |
| 47 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.43379265 |
| 48 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.42780922 |
| 49 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.41928880 |
| 50 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.35159225 |
| 51 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.33523762 |
| 52 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.33168627 |
| 53 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.31205768 |
| 54 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.29782260 |
| 55 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.29078099 |
| 56 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.27401874 |
| 57 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.27401874 |
| 58 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.23712559 |
| 59 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.22679919 |
| 60 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.21384876 |
| 61 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.21323874 |
| 62 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.20616637 |
| 63 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.20132465 |
| 64 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19720869 |
| 65 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.18943164 |
| 66 | FUS_26573619_Chip-Seq_HEK293_Human | 1.18789854 |
| 67 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 1.18121226 |
| 68 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.16510745 |
| 69 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.16333739 |
| 70 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.16098954 |
| 71 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.15583628 |
| 72 | GATA1_22025678_ChIP-Seq_K562_Human | 1.14978095 |
| 73 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.12196606 |
| 74 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.11246638 |
| 75 | TP53_16413492_ChIP-PET_HCT116_Human | 1.11207209 |
| 76 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.10949487 |
| 77 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.10684861 |
| 78 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.09502757 |
| 79 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.09384883 |
| 80 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.09372303 |
| 81 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.09131324 |
| 82 | * VDR_22108803_ChIP-Seq_LS180_Human | 1.08764036 |
| 83 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.08709487 |
| 84 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.08192236 |
| 85 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.08103286 |
| 86 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.07633405 |
| 87 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.07278321 |
| 88 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.06858889 |
| 89 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.06619974 |
| 90 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.06139136 |
| 91 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.06065816 |
| 92 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.06065816 |
| 93 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.05769527 |
| 94 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.04819282 |
| 95 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04766591 |
| 96 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.03933988 |
| 97 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03933988 |
| 98 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.03473760 |
| 99 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.03391038 |
| 100 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.02813851 |
| 101 | AR_19668381_ChIP-Seq_PC3_Human | 1.02669538 |
| 102 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.02191318 |
| 103 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.02090581 |
| 104 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.01546269 |
| 105 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.00824138 |
| 106 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00561047 |
| 107 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.99974154 |
| 108 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.98900356 |
| 109 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.98204664 |
| 110 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.98021143 |
| 111 | * GF1_26923725_Chip-Seq_HPCs_Mouse | 0.97447704 |
| 112 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.96099436 |
| 113 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.95646963 |
| 114 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.94127152 |
| 115 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.93568918 |
| 116 | AR_25329375_ChIP-Seq_VCAP_Human | 0.93545274 |
| 117 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.91334682 |
| 118 | * P300_18555785_Chip-Seq_ESCs_Mouse | 0.90344754 |
| 119 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.90255033 |
| 120 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.89729387 |
| 121 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.89433318 |
| 122 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.88327878 |
| 123 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.88031696 |
| 124 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.86195565 |
| 125 | KDM2B_26808549_Chip-Seq_REH_Human | 0.86181074 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000920_abnormal_myelination | 4.52395838 |
| 2 | MP0000751_myopathy | 4.35395435 |
| 3 | MP0003880_abnormal_central_pattern | 4.30725468 |
| 4 | MP0004084_abnormal_cardiac_muscle | 4.11655882 |
| 5 | MP0003646_muscle_fatigue | 3.99737102 |
| 6 | MP0004270_analgesia | 3.60428318 |
| 7 | MP0000749_muscle_degeneration | 3.42555962 |
| 8 | MP0004215_abnormal_myocardial_fiber | 3.36287839 |
| 9 | MP0004859_abnormal_synaptic_plasticity | 3.32152718 |
| 10 | MP0004130_abnormal_muscle_cell | 2.96441119 |
| 11 | MP0003690_abnormal_glial_cell | 2.93189860 |
| 12 | MP0001486_abnormal_startle_reflex | 2.88141054 |
| 13 | MP0002837_dystrophic_cardiac_calcinosis | 2.75588805 |
| 14 | MP0004510_myositis | 2.66910678 |
| 15 | * MP0002272_abnormal_nervous_system | 2.64510452 |
| 16 | MP0004885_abnormal_endolymph | 2.64205299 |
| 17 | MP0005423_abnormal_somatic_nervous | 2.60955543 |
| 18 | * MP0002064_seizures | 2.59856205 |
| 19 | MP0003635_abnormal_synaptic_transmissio | 2.55559271 |
| 20 | MP0001905_abnormal_dopamine_level | 2.48974079 |
| 21 | MP0004087_abnormal_muscle_fiber | 2.45883169 |
| 22 | MP0005620_abnormal_muscle_contractility | 2.43566169 |
| 23 | MP0009046_muscle_twitch | 2.39632718 |
| 24 | MP0004742_abnormal_vestibular_system | 2.39170692 |
| 25 | MP0004484_altered_response_of | 2.34628218 |
| 26 | MP0001529_abnormal_vocalization | 2.33334152 |
| 27 | MP0000778_abnormal_nervous_system | 2.31359141 |
| 28 | MP0003950_abnormal_plasma_membrane | 2.30920649 |
| 29 | MP0002972_abnormal_cardiac_muscle | 2.29775362 |
| 30 | * MP0009745_abnormal_behavioral_response | 2.27297447 |
| 31 | MP0002106_abnormal_muscle_physiology | 2.26032706 |
| 32 | MP0003136_yellow_coat_color | 2.24476902 |
| 33 | MP0004142_abnormal_muscle_tone | 2.23555592 |
| 34 | MP0005330_cardiomyopathy | 2.21054271 |
| 35 | MP0003329_amyloid_beta_deposits | 2.18858953 |
| 36 | MP0005171_absent_coat_pigmentation | 2.17641314 |
| 37 | MP0005409_darkened_coat_color | 2.17419367 |
| 38 | MP0003634_abnormal_glial_cell | 2.06999022 |
| 39 | MP0001485_abnormal_pinna_reflex | 2.05435394 |
| 40 | MP0002734_abnormal_mechanical_nocicepti | 1.98528774 |
| 41 | MP0002269_muscular_atrophy | 1.94591162 |
| 42 | MP0000759_abnormal_skeletal_muscle | 1.94467536 |
| 43 | MP0006138_congestive_heart_failure | 1.93582921 |
| 44 | MP0002572_abnormal_emotion/affect_behav | 1.90324427 |
| 45 | MP0002063_abnormal_learning/memory/cond | 1.89595632 |
| 46 | MP0005369_muscle_phenotype | 1.86427009 |
| 47 | MP0002332_abnormal_exercise_endurance | 1.81702027 |
| 48 | MP0002229_neurodegeneration | 1.72406120 |
| 49 | MP0005385_cardiovascular_system_phenoty | 1.68024420 |
| 50 | MP0001544_abnormal_cardiovascular_syste | 1.68024420 |
| 51 | MP0010630_abnormal_cardiac_muscle | 1.65951374 |
| 52 | MP0002127_abnormal_cardiovascular_syste | 1.61936057 |
| 53 | MP0003632_abnormal_nervous_system | 1.58907802 |
| 54 | MP0008775_abnormal_heart_ventricle | 1.58109206 |
| 55 | MP0005623_abnormal_meninges_morphology | 1.57699054 |
| 56 | MP0002067_abnormal_sensory_capabilities | 1.56842035 |
| 57 | MP0005551_abnormal_eye_electrophysiolog | 1.55631355 |
| 58 | MP0001440_abnormal_grooming_behavior | 1.54774071 |
| 59 | MP0000955_abnormal_spinal_cord | 1.54323362 |
| 60 | MP0002882_abnormal_neuron_morphology | 1.52181305 |
| 61 | MP0008569_lethality_at_weaning | 1.50872878 |
| 62 | MP0001968_abnormal_touch/_nociception | 1.49647385 |
| 63 | MP0000750_abnormal_muscle_regeneration | 1.46989399 |
| 64 | MP0001970_abnormal_pain_threshold | 1.44020967 |
| 65 | MP0004924_abnormal_behavior | 1.42605921 |
| 66 | MP0005386_behavior/neurological_phenoty | 1.42605921 |
| 67 | MP0005410_abnormal_fertilization | 1.41336004 |
| 68 | MP0003631_nervous_system_phenotype | 1.41267536 |
| 69 | MP0002638_abnormal_pupillary_reflex | 1.35701993 |
| 70 | * MP0002066_abnormal_motor_capabilities/c | 1.34918861 |
| 71 | MP0003633_abnormal_nervous_system | 1.34835274 |
| 72 | MP0003879_abnormal_hair_cell | 1.34500359 |
| 73 | MP0000569_abnormal_digit_pigmentation | 1.33828089 |
| 74 | MP0001963_abnormal_hearing_physiology | 1.32128346 |
| 75 | MP0000462_abnormal_digestive_system | 1.31914689 |
| 76 | MP0002822_catalepsy | 1.26773836 |
| 77 | MP0005645_abnormal_hypothalamus_physiol | 1.26474606 |
| 78 | MP0002733_abnormal_thermal_nociception | 1.26001518 |
| 79 | MP0002752_abnormal_somatic_nervous | 1.22353038 |
| 80 | MP0001501_abnormal_sleep_pattern | 1.21902325 |
| 81 | MP0010678_abnormal_skin_adnexa | 1.21218582 |
| 82 | MP0001346_abnormal_lacrimal_gland | 1.20422534 |
| 83 | MP0004145_abnormal_muscle_electrophysio | 1.19494669 |
| 84 | MP0002736_abnormal_nociception_after | 1.14366981 |
| 85 | MP0004043_abnormal_pH_regulation | 1.13939386 |
| 86 | MP0001984_abnormal_olfaction | 1.12326855 |
| 87 | MP0004233_abnormal_muscle_weight | 1.11611877 |
| 88 | MP0002735_abnormal_chemical_nociception | 1.10744140 |
| 89 | MP0000383_abnormal_hair_follicle | 1.10385270 |
| 90 | MP0002184_abnormal_innervation | 1.09882829 |
| 91 | MP0004134_abnormal_chest_morphology | 1.09122298 |
| 92 | MP0002108_abnormal_muscle_morphology | 1.06743258 |
| 93 | MP0003828_pulmonary_edema | 1.06245826 |
| 94 | MP0004381_abnormal_hair_follicle | 1.05808575 |
| 95 | MP0002557_abnormal_social/conspecific_i | 1.04484190 |
| 96 | MP0003045_fibrosis | 1.04014723 |
| 97 | MP0005670_abnormal_white_adipose | 1.03747430 |
| 98 | MP0000566_synostosis | 1.01868838 |
| 99 | MP0005646_abnormal_pituitary_gland | 1.01039481 |
| 100 | MP0000604_amyloidosis | 1.00850788 |
| 101 | MP0001299_abnormal_eye_distance/ | 1.00591725 |
| 102 | MP0008260_abnormal_autophagy | 1.00088560 |
| 103 | MP0001502_abnormal_circadian_rhythm | 0.99975342 |
| 104 | MP0001177_atelectasis | 0.99314712 |
| 105 | MP0001879_abnormal_lymphatic_vessel | 0.98226849 |
| 106 | MP0005195_abnormal_posterior_eye | 0.96829307 |
| 107 | MP0002152_abnormal_brain_morphology | 0.96213620 |
| 108 | MP0006276_abnormal_autonomic_nervous | 0.93882662 |
| 109 | MP0001188_hyperpigmentation | 0.93639706 |
| 110 | MP0000733_abnormal_muscle_development | 0.92712159 |
| 111 | MP0003938_abnormal_ear_development | 0.90400171 |
| 112 | MP0000026_abnormal_inner_ear | 0.90006886 |
| 113 | MP0004811_abnormal_neuron_physiology | 0.89311995 |
| 114 | MP0005666_abnormal_adipose_tissue | 0.87915701 |
| 115 | MP0005167_abnormal_blood-brain_barrier | 0.86136072 |
| 116 | MP0010368_abnormal_lymphatic_system | 0.85667226 |
| 117 | MP0000747_muscle_weakness | 0.83675891 |
| 118 | MP0005253_abnormal_eye_physiology | 0.82895255 |
| 119 | MP0000631_abnormal_neuroendocrine_gland | 0.79902893 |
| 120 | MP0006072_abnormal_retinal_apoptosis | 0.79066297 |
| 121 | MP0005165_increased_susceptibility_to | 0.77119951 |
| 122 | MP0003137_abnormal_impulse_conducting | 0.76631878 |
| 123 | MP0003122_maternal_imprinting | 0.71762822 |
| 124 | MP0003937_abnormal_limbs/digits/tail_de | 0.70714561 |
| 125 | MP0001661_extended_life_span | 0.69635339 |
| 126 | MP0001851_eye_inflammation | 0.68841029 |
| 127 | MP0009780_abnormal_chondrocyte_physiolo | 0.68764046 |
| 128 | MP0003221_abnormal_cardiomyocyte_apopto | 0.68164007 |
| 129 | MP0005451_abnormal_body_composition | 0.67856892 |
| 130 | MP0002102_abnormal_ear_morphology | 0.66850656 |
| 131 | MP0002971_abnormal_brown_adipose | 0.66555058 |
| 132 | MP0001348_abnormal_lacrimal_gland | 0.65466398 |
| 133 | MP0000230_abnormal_systemic_arterial | 0.65068978 |
| 134 | MP0001986_abnormal_taste_sensitivity | 0.63774538 |
| 135 | MP0002295_abnormal_pulmonary_circulatio | 0.63335915 |
| 136 | MP0001664_abnormal_digestion | 0.62498519 |
| 137 | MP0005266_abnormal_metabolism | 0.60533041 |
| 138 | MP0004085_abnormal_heartbeat | 0.60229412 |
| 139 | MP0004036_abnormal_muscle_relaxation | 0.59790954 |
| 140 | MP0005535_abnormal_body_temperature | 0.59586152 |
| 141 | MP0000266_abnormal_heart_morphology | 0.59495151 |
| 142 | MP0008874_decreased_physiological_sensi | 0.59417683 |
| 143 | MP0002090_abnormal_vision | 0.58909412 |
| 144 | MP0001943_abnormal_respiration | 0.58096065 |
| 145 | MP0000647_abnormal_sebaceous_gland | 0.56366722 |
| 146 | MP0003195_calcinosis | 0.55887758 |
| 147 | MP0000467_abnormal_esophagus_morphology | 0.55849808 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 6.23971782 |
| 2 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 6.20195009 |
| 3 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 6.20195009 |
| 4 | Muscle fiber inclusion bodies (HP:0100299) | 6.17332155 |
| 5 | Bundle branch block (HP:0011710) | 6.13205919 |
| 6 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.96495756 |
| 7 | Nemaline bodies (HP:0003798) | 5.90235939 |
| 8 | Neurofibrillary tangles (HP:0002185) | 5.85356007 |
| 9 | Hyporeflexia of lower limbs (HP:0002600) | 5.46898095 |
| 10 | Muscle fiber splitting (HP:0003555) | 5.26574755 |
| 11 | Type 1 muscle fiber predominance (HP:0003803) | 5.06461761 |
| 12 | Abnormality of the corticospinal tract (HP:0002492) | 4.78804143 |
| 13 | Subaortic stenosis (HP:0001682) | 4.64541929 |
| 14 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.64541929 |
| 15 | Exercise-induced myalgia (HP:0003738) | 4.55562907 |
| 16 | EMG: myopathic abnormalities (HP:0003458) | 4.51855859 |
| 17 | Calf muscle hypertrophy (HP:0008981) | 4.47943928 |
| 18 | Abnormality of the calf musculature (HP:0001430) | 4.38901238 |
| 19 | Peripheral hypomyelination (HP:0007182) | 4.33129108 |
| 20 | Cerebral inclusion bodies (HP:0100314) | 4.18661579 |
| 21 | Sensory axonal neuropathy (HP:0003390) | 4.17550233 |
| 22 | Parakeratosis (HP:0001036) | 4.13850825 |
| 23 | Atrial fibrillation (HP:0005110) | 4.07380976 |
| 24 | Exercise-induced muscle cramps (HP:0003710) | 4.03041360 |
| 25 | Syncope (HP:0001279) | 3.95451247 |
| 26 | Difficulty running (HP:0009046) | 3.91996555 |
| 27 | Ventricular tachycardia (HP:0004756) | 3.88868627 |
| 28 | Supranuclear gaze palsy (HP:0000605) | 3.87395940 |
| 29 | Primary atrial arrhythmia (HP:0001692) | 3.76457284 |
| 30 | Onion bulb formation (HP:0003383) | 3.75900139 |
| 31 | EMG: neuropathic changes (HP:0003445) | 3.75259204 |
| 32 | Asymmetric septal hypertrophy (HP:0001670) | 3.74388374 |
| 33 | Myokymia (HP:0002411) | 3.73974347 |
| 34 | Heart block (HP:0012722) | 3.72573109 |
| 35 | Spastic gait (HP:0002064) | 3.66199950 |
| 36 | Supraventricular arrhythmia (HP:0005115) | 3.59584407 |
| 37 | Supraventricular tachycardia (HP:0004755) | 3.58260781 |
| 38 | Focal motor seizures (HP:0011153) | 3.47114361 |
| 39 | Ankle clonus (HP:0011448) | 3.46402113 |
| 40 | Abnormal atrioventricular conduction (HP:0005150) | 3.39698064 |
| 41 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.35040780 |
| 42 | Intention tremor (HP:0002080) | 3.35028185 |
| 43 | Dysmetria (HP:0001310) | 3.31941501 |
| 44 | Ventricular fibrillation (HP:0001663) | 3.27900145 |
| 45 | Ventricular arrhythmia (HP:0004308) | 3.24636793 |
| 46 | Distal arthrogryposis (HP:0005684) | 3.23405455 |
| 47 | Lipoatrophy (HP:0100578) | 3.22979221 |
| 48 | Neck muscle weakness (HP:0000467) | 3.22022343 |
| 49 | Frequent falls (HP:0002359) | 3.09360957 |
| 50 | Rimmed vacuoles (HP:0003805) | 3.08955290 |
| 51 | Termporal pattern (HP:0011008) | 3.06154471 |
| 52 | Insidious onset (HP:0003587) | 3.06154471 |
| 53 | Alacrima (HP:0000522) | 3.03833051 |
| 54 | Cerebral hypomyelination (HP:0006808) | 2.97139219 |
| 55 | Dilated cardiomyopathy (HP:0001644) | 2.96524797 |
| 56 | Retinal dysplasia (HP:0007973) | 2.92880806 |
| 57 | Distal lower limb muscle weakness (HP:0009053) | 2.92397452 |
| 58 | Scanning speech (HP:0002168) | 2.86630878 |
| 59 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.84621110 |
| 60 | Abnormality of the foot musculature (HP:0001436) | 2.83935697 |
| 61 | Abnormal auditory evoked potentials (HP:0006958) | 2.81476357 |
| 62 | Febrile seizures (HP:0002373) | 2.78819150 |
| 63 | Increased circulating renin level (HP:0000848) | 2.77786696 |
| 64 | Areflexia of lower limbs (HP:0002522) | 2.76604013 |
| 65 | Prolonged QT interval (HP:0001657) | 2.71757923 |
| 66 | Hemiplegia (HP:0002301) | 2.69741343 |
| 67 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.69537964 |
| 68 | Atrioventricular block (HP:0001678) | 2.64911642 |
| 69 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.64753001 |
| 70 | Slow saccadic eye movements (HP:0000514) | 2.62532521 |
| 71 | Metabolic alkalosis (HP:0200114) | 2.62444461 |
| 72 | Dysmetric saccades (HP:0000641) | 2.61928116 |
| 73 | Increased variability in muscle fiber diameter (HP:0003557) | 2.61909816 |
| 74 | Clumsiness (HP:0002312) | 2.60898748 |
| 75 | Pheochromocytoma (HP:0002666) | 2.57349513 |
| 76 | Myoglobinuria (HP:0002913) | 2.57087229 |
| 77 | Myotonia (HP:0002486) | 2.52892052 |
| 78 | Atonic seizures (HP:0010819) | 2.49161695 |
| 79 | Limb dystonia (HP:0002451) | 2.49062623 |
| 80 | Generalized muscle weakness (HP:0003324) | 2.47831619 |
| 81 | Focal seizures (HP:0007359) | 2.47579462 |
| 82 | Abnormal EKG (HP:0003115) | 2.46285296 |
| 83 | Cerebral hemorrhage (HP:0001342) | 2.46127559 |
| 84 | Akinesia (HP:0002304) | 2.45622516 |
| 85 | Lower limb muscle weakness (HP:0007340) | 2.44601850 |
| 86 | Absent septum pellucidum (HP:0001331) | 2.42577706 |
| 87 | Thickened helices (HP:0000391) | 2.42562635 |
| 88 | Decreased lacrimation (HP:0000633) | 2.41612797 |
| 89 | Autoamputation (HP:0001218) | 2.41528797 |
| 90 | Aplasia involving bones of the extremities (HP:0009825) | 2.41352810 |
| 91 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.41352810 |
| 92 | Aplasia of the phalanges of the hand (HP:0009802) | 2.41352810 |
| 93 | Rhabdomyolysis (HP:0003201) | 2.40924820 |
| 94 | Postural instability (HP:0002172) | 2.38832252 |
| 95 | Anteriorly placed anus (HP:0001545) | 2.37311678 |
| 96 | Increased connective tissue (HP:0009025) | 2.36186126 |
| 97 | Action tremor (HP:0002345) | 2.34515157 |
| 98 | Round ear (HP:0100830) | 2.34437335 |
| 99 | Epileptic encephalopathy (HP:0200134) | 2.33115443 |
| 100 | Myopathic facies (HP:0002058) | 2.32351327 |
| 101 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.28277533 |
| 102 | Left ventricular hypertrophy (HP:0001712) | 2.27329850 |
| 103 | Leukodystrophy (HP:0002415) | 2.27285474 |
| 104 | Neuroendocrine neoplasm (HP:0100634) | 2.20765300 |
| 105 | Premature skin wrinkling (HP:0100678) | 2.18652238 |
| 106 | Morphological abnormality of the inner ear (HP:0011390) | 2.18285234 |
| 107 | Hypoplasia of the iris (HP:0007676) | 2.18182495 |
| 108 | Hypomagnesemia (HP:0002917) | 2.17157442 |
| 109 | Split foot (HP:0001839) | 2.17044902 |
| 110 | Hypokalemic alkalosis (HP:0001949) | 2.15209155 |
| 111 | Hypoplastic pelvis (HP:0008839) | 2.12197323 |
| 112 | Broad-based gait (HP:0002136) | 2.09318813 |
| 113 | Scapular winging (HP:0003691) | 2.05745484 |
| 114 | Abnormality of the septum pellucidum (HP:0007375) | 2.05553826 |
| 115 | Dysdiadochokinesis (HP:0002075) | 2.03650461 |
| 116 | Coronal craniosynostosis (HP:0004440) | 2.03004342 |
| 117 | White forelock (HP:0002211) | 2.01076944 |
| 118 | Dialeptic seizures (HP:0011146) | 2.00562772 |
| 119 | Fetal akinesia sequence (HP:0001989) | 2.00075125 |
| 120 | Clonus (HP:0002169) | 1.98953454 |
| 121 | Hyperventilation (HP:0002883) | 1.98715913 |
| 122 | Synostosis involving the elbow (HP:0003938) | 1.98373819 |
| 123 | Humeroradial synostosis (HP:0003041) | 1.98373819 |
| 124 | CNS hypomyelination (HP:0003429) | 1.97386303 |
| 125 | Generalized tonic-clonic seizures (HP:0002069) | 1.96693553 |
| 126 | Urinary urgency (HP:0000012) | 1.95766043 |
| 127 | Megalencephaly (HP:0001355) | 1.92339010 |
| 128 | Patchy hypopigmentation of hair (HP:0011365) | 1.91975608 |
| 129 | Papillary thyroid carcinoma (HP:0002895) | 1.91530971 |
| 130 | Ulnar deviation of the wrist (HP:0003049) | 1.90223847 |
| 131 | Stridor (HP:0010307) | 1.89804642 |
| 132 | Lower limb amyotrophy (HP:0007210) | 1.89059176 |
| 133 | Muscular dystrophy (HP:0003560) | 1.88889067 |
| 134 | Hammertoe (HP:0001765) | 1.88303338 |
| 135 | Diplopia (HP:0000651) | 1.88135368 |
| 136 | Abnormality of binocular vision (HP:0011514) | 1.88135368 |
| 137 | Steppage gait (HP:0003376) | 1.87195391 |
| 138 | Generalized myoclonic seizures (HP:0002123) | 1.87180475 |
| 139 | Foot dorsiflexor weakness (HP:0009027) | 1.86929152 |
| 140 | Hyperkalemia (HP:0002153) | 1.85660032 |
| 141 | Progressive cerebellar ataxia (HP:0002073) | 1.85612423 |
| 142 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.84957905 |
| 143 | Decreased motor nerve conduction velocity (HP:0003431) | 1.84635648 |
| 144 | Septo-optic dysplasia (HP:0100842) | 1.83843543 |
| 145 | Progressive inability to walk (HP:0002505) | 1.83816509 |
| 146 | Partial duplication of thumb phalanx (HP:0009944) | 1.83721430 |
| 147 | Gaze-evoked nystagmus (HP:0000640) | 1.83628370 |
| 148 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.83551040 |
| 149 | Bowel incontinence (HP:0002607) | 1.83492094 |
| 150 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.83348509 |
| 151 | Absence seizures (HP:0002121) | 1.82746476 |
| 152 | Hip contracture (HP:0003273) | 1.82699400 |
| 153 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.82556348 |
| 154 | Widely spaced teeth (HP:0000687) | 1.82239468 |
| 155 | Vaginal atresia (HP:0000148) | 1.82040252 |
| 156 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.82032585 |
| 157 | Cupped ear (HP:0000378) | 1.81049492 |
| 158 | Esophageal atresia (HP:0002032) | 1.80883627 |
| 159 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.80569757 |
| 160 | Absent/shortened dynein arms (HP:0200106) | 1.80569757 |
| 161 | Truncal ataxia (HP:0002078) | 1.80426660 |
| 162 | Rapidly progressive (HP:0003678) | 1.80424798 |
| 163 | Spastic tetraparesis (HP:0001285) | 1.80213357 |
| 164 | Infantile muscular hypotonia (HP:0008947) | 1.80002020 |
| 165 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.79940972 |
| 166 | Difficulty climbing stairs (HP:0003551) | 1.79688317 |
| 167 | Type II lissencephaly (HP:0007260) | 1.77398184 |
| 168 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.77144902 |
| 169 | Hemiparesis (HP:0001269) | 1.76485122 |
| 170 | Anomalous pulmonary venous return (HP:0010772) | 1.75340819 |
| 171 | Genital tract atresia (HP:0001827) | 1.75143475 |
| 172 | Distal lower limb amyotrophy (HP:0008944) | 1.74341707 |
| 173 | Gowers sign (HP:0003391) | 1.73735885 |
| 174 | Right ventricular cardiomyopathy (HP:0011663) | 1.73448912 |
| 175 | Bulbar palsy (HP:0001283) | 1.73277831 |
| 176 | Absent phalangeal crease (HP:0006109) | 1.73225960 |
| 177 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.71586838 |
| 178 | Papilledema (HP:0001085) | 1.70378403 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 6.08691355 |
| 2 | STK39 | 5.79926529 |
| 3 | OXSR1 | 4.46572290 |
| 4 | TTN | 3.47945401 |
| 5 | EPHB1 | 3.20033436 |
| 6 | PKN1 | 2.58828894 |
| 7 | CDK19 | 2.49553699 |
| 8 | TNIK | 2.38497189 |
| 9 | MAPKAPK5 | 2.30490281 |
| 10 | WNK4 | 2.30312436 |
| 11 | BCR | 2.24962519 |
| 12 | DMPK | 2.16352447 |
| 13 | MAPK12 | 2.11928073 |
| 14 | WNK1 | 1.94882176 |
| 15 | PNCK | 1.92476752 |
| 16 | CASK | 1.86126462 |
| 17 | FGFR2 | 1.79788373 |
| 18 | SGK2 | 1.77108236 |
| 19 | EPHA4 | 1.74033972 |
| 20 | UHMK1 | 1.73031731 |
| 21 | NTRK1 | 1.72809248 |
| 22 | CSNK1G3 | 1.70105241 |
| 23 | MARK1 | 1.68119542 |
| 24 | PAK6 | 1.61745144 |
| 25 | NEK6 | 1.60327179 |
| 26 | MAP3K7 | 1.57009609 |
| 27 | PBK | 1.51700612 |
| 28 | CSNK1A1L | 1.51272026 |
| 29 | PRPF4B | 1.44870496 |
| 30 | MET | 1.44402058 |
| 31 | CAMK2B | 1.41115146 |
| 32 | ICK | 1.39870122 |
| 33 | CSNK1G2 | 1.38260588 |
| 34 | MYLK | 1.37889532 |
| 35 | CSNK1G1 | 1.33878939 |
| 36 | PIK3CG | 1.33675555 |
| 37 | SGK223 | 1.32462943 |
| 38 | SGK494 | 1.32462943 |
| 39 | ROCK2 | 1.32176472 |
| 40 | CLK1 | 1.31227069 |
| 41 | SGK3 | 1.31082152 |
| 42 | TESK2 | 1.29273157 |
| 43 | FGR | 1.25386288 |
| 44 | CAMK4 | 1.23388356 |
| 45 | LIMK1 | 1.23330034 |
| 46 | NTRK3 | 1.21893943 |
| 47 | CAMK2D | 1.19557724 |
| 48 | TIE1 | 1.15651086 |
| 49 | RIPK1 | 1.12903689 |
| 50 | MAPK13 | 1.11711363 |
| 51 | IRAK2 | 1.09485248 |
| 52 | CDK5 | 1.07511825 |
| 53 | EPHA3 | 1.05925884 |
| 54 | PAK3 | 1.01945898 |
| 55 | CAMKK2 | 1.01183258 |
| 56 | MUSK | 1.00801806 |
| 57 | NLK | 0.99735888 |
| 58 | PDK2 | 0.99274748 |
| 59 | TYRO3 | 0.98056323 |
| 60 | CAMK2A | 0.97171145 |
| 61 | MARK2 | 0.95709487 |
| 62 | NTRK2 | 0.95663929 |
| 63 | TRPM7 | 0.93600798 |
| 64 | FES | 0.93099520 |
| 65 | KSR1 | 0.92981515 |
| 66 | CAMKK1 | 0.91642967 |
| 67 | BMPR1B | 0.91098526 |
| 68 | CAMK2G | 0.90581834 |
| 69 | CDK14 | 0.85073461 |
| 70 | MAP3K13 | 0.84335172 |
| 71 | PHKG2 | 0.81967918 |
| 72 | PHKG1 | 0.81967918 |
| 73 | PRKCQ | 0.81807667 |
| 74 | RAF1 | 0.78469907 |
| 75 | PRKCE | 0.77575253 |
| 76 | DYRK2 | 0.77558248 |
| 77 | MAP2K4 | 0.76899129 |
| 78 | CDK15 | 0.76179447 |
| 79 | RIPK4 | 0.74904214 |
| 80 | RET | 0.74336460 |
| 81 | CAMK1G | 0.73201455 |
| 82 | PRKAA1 | 0.73149438 |
| 83 | STK11 | 0.72489757 |
| 84 | CDK18 | 0.72211612 |
| 85 | MOS | 0.70645561 |
| 86 | MAPK15 | 0.70041383 |
| 87 | PDPK1 | 0.68649939 |
| 88 | CDK11A | 0.68167963 |
| 89 | MAP3K9 | 0.66449058 |
| 90 | PRKD1 | 0.64798308 |
| 91 | ZAP70 | 0.64556493 |
| 92 | PRKAA2 | 0.63929754 |
| 93 | FYN | 0.62955272 |
| 94 | MAPK4 | 0.60790719 |
| 95 | ARAF | 0.59901289 |
| 96 | RPS6KA3 | 0.58654883 |
| 97 | MINK1 | 0.58337187 |
| 98 | PRKCH | 0.57837654 |
| 99 | BLK | 0.57300697 |
| 100 | MAP2K7 | 0.55561950 |
| 101 | PINK1 | 0.54995763 |
| 102 | NEK9 | 0.54772989 |
| 103 | LATS2 | 0.54543911 |
| 104 | MAP2K3 | 0.53256091 |
| 105 | GRK7 | 0.53127383 |
| 106 | MAP3K4 | 0.51415290 |
| 107 | JAK2 | 0.51322225 |
| 108 | PRKD3 | 0.50849804 |
| 109 | MAP3K2 | 0.49807680 |
| 110 | PRKG1 | 0.49083518 |
| 111 | ADRBK2 | 0.48555879 |
| 112 | ERBB4 | 0.46473217 |
| 113 | IRAK1 | 0.45097846 |
| 114 | MST4 | 0.44505587 |
| 115 | BMPR2 | 0.44222371 |
| 116 | PDK1 | 0.43530445 |
| 117 | PLK2 | 0.43131546 |
| 118 | CSNK1A1 | 0.42773452 |
| 119 | CSNK1D | 0.42558694 |
| 120 | MAP2K1 | 0.42410049 |
| 121 | FGFR3 | 0.42227154 |
| 122 | PIK3CA | 0.42144748 |
| 123 | * PRKACA | 0.41508864 |
| 124 | PTK2B | 0.41298317 |
| 125 | MAP3K1 | 0.41152891 |
| 126 | JAK1 | 0.40410479 |
| 127 | PDGFRB | 0.40242560 |
| 128 | CCNB1 | 0.40104087 |
| 129 | STK38 | 0.38908284 |
| 130 | SGK1 | 0.37702121 |
| 131 | PRKACB | 0.37411462 |
| 132 | GRK5 | 0.36102830 |
| 133 | MAPKAPK3 | 0.35319072 |
| 134 | GSK3A | 0.35088512 |
| 135 | RPS6KA5 | 0.34132680 |
| 136 | DAPK2 | 0.33724284 |
| 137 | WNK3 | 0.33603341 |
| 138 | KSR2 | 0.33386213 |
| 139 | CAMK1 | 0.32406642 |
| 140 | MAPK7 | 0.32300891 |
| 141 | ROCK1 | 0.30883702 |
| 142 | DYRK1A | 0.30656638 |
| 143 | MAPK10 | 0.29649728 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 3.77026420 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.11308849 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.98915365 |
| 4 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.77147652 |
| 5 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.66776350 |
| 6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.36455609 |
| 7 | Axon guidance_Homo sapiens_hsa04360 | 2.04224359 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.03420414 |
| 9 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.02374908 |
| 10 | * GABAergic synapse_Homo sapiens_hsa04727 | 1.95533889 |
| 11 | Nicotine addiction_Homo sapiens_hsa05033 | 1.91477731 |
| 12 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.89015234 |
| 13 | Morphine addiction_Homo sapiens_hsa05032 | 1.83514847 |
| 14 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.82819948 |
| 15 | Circadian rhythm_Homo sapiens_hsa04710 | 1.72296103 |
| 16 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.56477396 |
| 17 | Circadian entrainment_Homo sapiens_hsa04713 | 1.56449769 |
| 18 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.55340948 |
| 19 | Long-term depression_Homo sapiens_hsa04730 | 1.52833288 |
| 20 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.49868328 |
| 21 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.48335143 |
| 22 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.46164689 |
| 23 | Cocaine addiction_Homo sapiens_hsa05030 | 1.43803908 |
| 24 | Salivary secretion_Homo sapiens_hsa04970 | 1.39909338 |
| 25 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.37400612 |
| 26 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.36210957 |
| 27 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.30327566 |
| 28 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.27419409 |
| 29 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.26556625 |
| 30 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.20165504 |
| 31 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.18995484 |
| 32 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.17414424 |
| 33 | Renin secretion_Homo sapiens_hsa04924 | 1.16782315 |
| 34 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.15428055 |
| 35 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.15417752 |
| 36 | Phototransduction_Homo sapiens_hsa04744 | 1.15243758 |
| 37 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.13477738 |
| 38 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.11594071 |
| 39 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.10322299 |
| 40 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.08406853 |
| 41 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.08187901 |
| 42 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.07567632 |
| 43 | Olfactory transduction_Homo sapiens_hsa04740 | 1.07299268 |
| 44 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.07020091 |
| 45 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.03599334 |
| 46 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.02919283 |
| 47 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.02433823 |
| 48 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.01894714 |
| 49 | Glioma_Homo sapiens_hsa05214 | 1.00140706 |
| 50 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.99415388 |
| 51 | Histidine metabolism_Homo sapiens_hsa00340 | 0.98926909 |
| 52 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.98629019 |
| 53 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.97016554 |
| 54 | Taste transduction_Homo sapiens_hsa04742 | 0.96692695 |
| 55 | Long-term potentiation_Homo sapiens_hsa04720 | 0.95406009 |
| 56 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.95255882 |
| 57 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.94163527 |
| 58 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.94116279 |
| 59 | Endometrial cancer_Homo sapiens_hsa05213 | 0.94005645 |
| 60 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.93110014 |
| 61 | Platelet activation_Homo sapiens_hsa04611 | 0.92262543 |
| 62 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.91107512 |
| 63 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.90235034 |
| 64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.90231244 |
| 65 | Alzheimers disease_Homo sapiens_hsa05010 | 0.89318483 |
| 66 | Gap junction_Homo sapiens_hsa04540 | 0.87978105 |
| 67 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.86944357 |
| 68 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.86890128 |
| 69 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.86509263 |
| 70 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.85986534 |
| 71 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.85417278 |
| 72 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.85363162 |
| 73 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.84793998 |
| 74 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.83892418 |
| 75 | Focal adhesion_Homo sapiens_hsa04510 | 0.82653715 |
| 76 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.81987068 |
| 77 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.81703146 |
| 78 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.81341387 |
| 79 | Insulin secretion_Homo sapiens_hsa04911 | 0.81046995 |
| 80 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.80991660 |
| 81 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.80965155 |
| 82 | Protein export_Homo sapiens_hsa03060 | 0.80293882 |
| 83 | Endocytosis_Homo sapiens_hsa04144 | 0.80182818 |
| 84 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.79940677 |
| 85 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.79912221 |
| 86 | Tight junction_Homo sapiens_hsa04530 | 0.79911815 |
| 87 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.79874991 |
| 88 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.78993086 |
| 89 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.78864703 |
| 90 | Insulin resistance_Homo sapiens_hsa04931 | 0.77326270 |
| 91 | Parkinsons disease_Homo sapiens_hsa05012 | 0.76119024 |
| 92 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.75181933 |
| 93 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.74001104 |
| 94 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.73350900 |
| 95 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.72305719 |
| 96 | Bile secretion_Homo sapiens_hsa04976 | 0.71859820 |
| 97 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.69314248 |
| 98 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.66133042 |
| 99 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.65198740 |
| 100 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.63873502 |
| 101 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.62627961 |
| 102 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.61158593 |
| 103 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.60952371 |
| 104 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.60279026 |
| 105 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.60211531 |
| 106 | Adherens junction_Homo sapiens_hsa04520 | 0.59774894 |
| 107 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.59285159 |
| 108 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.59033447 |
| 109 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.57719140 |
| 110 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.57279844 |
| 111 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.56026264 |
| 112 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.55821364 |
| 113 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.55594624 |
| 114 | ABC transporters_Homo sapiens_hsa02010 | 0.55120903 |
| 115 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.55045117 |
| 116 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.54751459 |
| 117 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.54405377 |
| 118 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.54158905 |
| 119 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.52648424 |
| 120 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.51865710 |
| 121 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.51033463 |
| 122 | Lysosome_Homo sapiens_hsa04142 | 0.50328606 |
| 123 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.49319782 |
| 124 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.48587018 |
| 125 | Melanogenesis_Homo sapiens_hsa04916 | 0.48184166 |
| 126 | Phagosome_Homo sapiens_hsa04145 | 0.47387198 |
| 127 | Amoebiasis_Homo sapiens_hsa05146 | 0.47261350 |
| 128 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.47156767 |
| 129 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.46810692 |
| 130 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.45966026 |
| 131 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.45651867 |
| 132 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.45642201 |
| 133 | Mineral absorption_Homo sapiens_hsa04978 | 0.44385821 |
| 134 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.43373946 |
| 135 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.43303447 |
| 136 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.42195715 |
| 137 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.39564023 |
| 138 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.39388898 |
| 139 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.36792151 |
| 140 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.36276754 |
| 141 | Prion diseases_Homo sapiens_hsa05020 | 0.35841560 |
| 142 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.34244058 |

